Sildenafil: study of a novel oral treatm
β
Price, D.E.; Gingell, J.C.; Gepi-Attee, S.; Wareham, K.; Yates, P.; Boolell, M.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 94 KB
π 1 views
The efficacy and safety of oral sildenafil, a potent inhibitor of phosphodiesterase type 5, were evaluated in men with diabetes mellitus and erectile dysfunction (ED). Twenty-one men (aged 42-65 years) were enrolled in a double-blind, placebo-controlled, three-way crossover study conducted in two pa